NCT03059888View on ClinicalTrials.gov

Trial of Orencia in Patients With Myasthenia Gravis

EARLY_PHASE1TerminatedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

April 12, 2017

Primary Completion Date

July 15, 2019

Study Completion Date

July 15, 2019

Conditions

Myasthenia Gravis

Interventions

DRUG

Abatacept Injection

Subcutaneous administration of abatacept

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Johns Hopkins University

OTHER